- Home
- App Analytics
- SARCULATOR
- SARCULATOR Vs. ASCO Guidelines
SARCULATOR vs ASCO Guidelines Uso e estatísticas
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
SARCULATOR versus ASCO Guidelines comparação de classificação
Compare a tendência de classificação de SARCULATOR nos últimos 28 dias versus ASCO Guidelines
Classificação
Nenhum dado disponível
Comparação da classificação de SARCULATOR vs. ASCO Guidelines por país
Compare a tendência de classificação de SARCULATOR nos últimos 28 dias versus ASCO Guidelines
Todas as categorias
Nenhum dado disponível
Médico
Faça comparações com qualquer site com o nosso teste grátis
SARCULATOR VS.
ASCO Guidelines
janeiro 8, 2025